EUVIMEDEUVIMED entdecken
Open Access

Ultrafast dynamic contrast-enhanced magnetic resonance imaging in distinguishing benign from malignant nonmass enhancement and excluding lesions that do not require treatment

Naoko Mori iD, Toshiki Murata, Masazumi Matsuda

British Journal of Radiology · 2024

DOI: 10.1093/bjr/tqae127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Radiology, 2024. Verfasst von Naoko Mori und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Akita University Graduate School of Medicine, Akita 010-8543, Japan. Hauptthemen laut MEDLINE: Contrast Media, Magnetic Resonance Imaging. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To the editor, We read the article by Juliano et al, titled “Clinical role of abbreviated and ultrafast mri in breast imaging” with interest.1 We greatly appreciate their review article showing the role of abbreviated breast MRI and ultrafast dynamic contrast-enhanced (DCE)-MRI in breast imaging, especially in breast cancer screening. We would add to their review the potential role of ultrafast DCE-MRI in distinguishing benign from malignant nonmass enhancement (NME) and excluding lesions that do not require treatment. Historically, the NME lesions have been difficult to distinguish as benign or malignant on breast cancer screening MRI. Baltzer et al reported that the NMEs were the major cause of false-positive breast MRI findings and Breast Imaging Reporting and Data System morphologic evaluation was insufficient to differentiate benign and malignant NMEs.2 Goto et al reported that enhancement patterns of kinetic analysis using standard DCE-MRI were not statistically significantly different between benign and malignant NMEs.3 Recently, we reported that the kinetic parameters of ultrafast and standard DCE-MRI were as effective as morphologic evaluation for differentiation between benign and malignant NMEs.4 We suppose that these conflicting results between Baltzer, Goto, and us might be attributable to continued development of MRI systems, such as improvement of signal-to-noise ratio and spatial resolution.5 If the kinematic parameters of ultrafast DCE-MRI can discriminate between benign and malignant as well as morphologic evaluation, it would be especially useful in cases where morphologic evaluation is difficult or where the radiologist does not have sufficient experience to perform morphologic evaluation. Similarly, in the combination of abbreviated MRI and ultrafast DCE-MRI they proposed in their review, the kinematic parameters of ultrafast DCE-MRI might be effective in cases where morphologic evaluation is difficult or where the radiologist does not have sufficient experience to perform morphologic evaluation. In excluding lesions that do not require treatment, an understanding of the management of ductal carcinoma in situ (DCIS) is important. DCIS accounts for approximately 20% of newly diagnosed breast cancers after the introduction of population-based screening mammography.6 These increased DCIS cases have raised concerns about the overdiagnosis of DCIS.7 A significant portion of the DCIS lesions detected by screening mammography may not have been clinically present or life-threatening to the patient in the absence of screening. Non-surgical management of non-life-threatening DCIS through active surveillance has received much attention, and several clinical trials are ongoing.8 Regarding how imaging can inform DCIS management, DCE-MRI is the most sensitive tool for detecting and characterizing the extent of DCIS.7 However, for grading DCIS lesions, morphological evaluation and kinetic analysis of standard DCE-MRI showed that low-risk DCIS and non-low-risk DCIS did not differ significantly.9 In recent years, when ultrafast DCE-MRI has become available, we performed texture analysis of ultrafast DCE-MRI and found that a model with texture features, including shape, could effectively distinguish low-risk DCIS from non-low-risk DCIS.10 Ultrafast DCE-MRI may be useful for detecting low-risk DCIS that do not require treatment. We again appreciate the authors’ great effort toward showing the role of abbreviated breast MRI and ultrafast DCE-MRI in breast cancer screening. None declared. None declared.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contrast MediaMagnetic Resonance ImagingHumansDiagnosis, DifferentialFemaleMiddle AgedMaleAgedAdultImage EnhancementNeoplasms

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Radiology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.

ORCID-Profile: Naoko Mori

Zitieren

APA

Mori, N., Murata, T., & Matsuda, M. (2024). Ultrafast dynamic contrast-enhanced magnetic resonance imaging in distinguishing benign from malignant nonmass enhancement and excluding lesions that do not require treatment. British Journal of Radiology. https://doi.org/10.1093/bjr/tqae127

Vancouver

Mori N, Murata T, Matsuda M. Ultrafast dynamic contrast-enhanced magnetic resonance imaging in distinguishing benign from malignant nonmass enhancement and excluding lesions that do not require treatment. British Journal of Radiology. 2024. doi:10.1093/bjr/tqae127

BibTeX
@article{Mori2024,
  author = {Mori, Naoko and Murata, Toshiki and Matsuda, Masazumi},
  title = {Ultrafast dynamic contrast-enhanced magnetic resonance imaging in distinguishing benign from malignant nonmass enhancement and excluding lesions that do not require treatment},
  journal = {British Journal of Radiology},
  year = {2024},
  doi = {10.1093/bjr/tqae127}
}
Kostenlos starten →